FDA Approves Pooled Sample Test for COVID-19

The US Food and Drug Administration (FDA) has reissued an Emergency Use Authorization (EUA) to Quest Diagnostics for its Quest SARS-CoV-2 rRT-PCR test that can now be run with pooled samples containing up to four individual collected specimens. With this, Quest’s test becomes the first COVID-19 diagnostic that is authorized for use with pooled samples.